Michael Whyte

9PUBLICATIONS
22CO-AUTHORS
Pacific Peoples diet and nutritionPaediatrics not elsewhere classifiedPredictive and prognostic markersDevelopmental genetics (incl. sex determination)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 14, 2026
Hypophosphatasia: who among us is a carrier?

Michael P Whyte

|Jun 21, 2024
Pediatric hypophosphatasia: avoid diagnosis missteps!

Michael P Whyte, William H McAlister, Karen E Mack

|Apr 17, 2023
LRP6 High Bone Mass Characterized in Two Generations Harboring a Unique Mutation of Low-Density Lipoprotein Receptor-Related Protein 6.

Michael P Whyte, Steven Mumm, Jonathan C Baker

|Aug 22, 2022
Dysosteosclerosis: Clinical and Radiological Evolution Reflecting Genetic Heterogeneity.

Serap Turan, Steven Mumm, Ceren Alavanda

|Mar 19, 2021
Tumor-Induced Osteomalacia: Treatment Progress Using Burosumab, an Anti-FGF23 Monoclonal Antibody.

Michael P Whyte

|Jan 23, 2021
Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia.

Raja Padidela, Michael P Whyte, Francis H Glorieux

Pageof 2

Frequent Collaborators

2 joint publications

Steven Mumm

1 joint publications

Fernando Gianfrancesco

1 joint publications

Raja Padidela

1 joint publications

Francis H Glorieux